Paul Vincent Goode

US Patent:

7081195, Jul 25, 2006

Filed:

Dec 7, 2004

Appl. No.:

11/007635

Inventors:

Peter Simpson - Del Mar CA, US
James Brauker - San Diego CA, US
Victoria Carr-Brendel - Pleasanton CA, US
Paul Goode - Cherry Hill NJ, US
Mark Tapsak - Orangeville PA, US

Assignee:

DexCom, inc. - San Diego CA

International Classification:

G01N 27/327

US Classification:

2057775, 205792, 20440301, 20440311

Abstract:

An analyte-measuring device, particularly an electrochemical sensor, is provided for measuring current values at multiple bias potential settings to assess the quality of the analyte measurement, identify interference in the signal, and calculate substantially interference-free analyte concentration measurements. The device and method are suitable for calculating substantially interference-free analyte concentration measurements when glucose is the analyte and acetaminophen is an interfering species.

US Patent:

7108778, Sep 19, 2006

Filed:

Jul 21, 2004

Appl. No.:

10/897377

Inventors:

Peter C. Simpson - Del Mar CA, US
Paul Goode - Murrieta CA, US
Mark A. Tapsak - Orangeville PA, US
Victoria Carr-Brendel - Pleasanton CA, US

Assignee:

DexCom, Inc. - San Diego CA

International Classification:

G01N 27/327

US Classification:

205778, 2057775, 2044031, 20440309, 20440314

Abstract:

The present invention relates generally to systems and methods for increasing oxygen generation in electrochemical sensors in order to overcome the oxygen limitations. The preferred embodiments employ electrode systems with at least two electrodes in relatively close proximity to each other; wherein at least one electrode is configured to generate oxygen and at least one other electrode is configured to sense an analyte or a product of a reaction indicative of the concentration of analyte. The oxygen generated by the oxygen-generating electrode is available to the catalyst within a membrane system and/or the counter electrode, thereby enabling the electrochemical sensors of the preferred embodiments to function even during ischemic conditions.

US Patent:

7171258, Jan 30, 2007

Filed:

Jun 25, 2003

Appl. No.:

10/603876

Inventors:

Paul Goode - Murrieta CA, US

Assignee:

Cardiac Pacemakers, Inc. - St. Paul MN

International Classification:

A61B 5/04
A61N 1/00

US Classification:

600509, 607 17

Abstract:

The present invention relates to an implantable cardioverter-defibrillator or pacemaker whose standard circuitry is used to trend a physiological cardiac parameter using intra-cardiac impedance measurements. The trend information may be used to predict the onset of a sudden cardiac death (SCD) event. By being able to predict the onset of an SCD event, patients and their physicians may be forewarned of a life-threatening event allowing them to respond accordingly. The trend information may also be used to predict the efficacy of cardiac-related medications, monitor progress of congestive heart failure, detect the occurrence of myocardial infarction, or simply track changes in sympathetic tone.

US Patent:

7693560, Apr 6, 2010

Filed:

Mar 27, 2007

Appl. No.:

11/692154

Inventors:

Peter C. Simpson - Encinitas CA, US
James H. Brauker - San Diego CA, US
Paul V. Goode - Cherry Hill NJ, US
Apurv U. Kamath - San Diego CA, US
James R. Petisce - San Diego CA, US
Kum Ming Woo - San Diego CA, US
Melissa A. Nicholas - San Diego CA, US
Robert J. Boock - San Diego CA, US
Monica A. Rixman - San Diego CA, US
John Burd - San Diego CA, US
Rathburn K. Rhodes - Madison WI, US
Mark A. Tapsak - Orangeville PA, US

Assignee:

DexCom, Inc. - San Diego CA

International Classification:

A61B 5/00

US Classification:

600345, 600347, 600365

Abstract:

Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.

US Patent:

7761130, Jul 20, 2010

Filed:

Mar 27, 2007

Appl. No.:

11/692154

Inventors:

Peter C. Simpson - Encinitas CA, US
James H. Brauker - San Diego CA, US
Paul V. Goode - Cherry Hill NJ, US
Apurv U. Kamath - San Diego CA, US
James R. Petisce - San Diego CA, US
Kum Ming Woo - San Diego CA, US
Melissa A. Nicholas - San Diego CA, US
Robert J. Boock - San Diego CA, US
Monica A. Rixman - San Diego CA, US
John Burd - San Diego CA, US
Rathbun K. Rhodes - Madison WI, US
Mark A. Tapsak - Orangeville PA, US

Assignee:

DexCom, Inc. - San Diego CA

International Classification:

A61B 5/00

US Classification:

600345, 600347, 600365

Abstract:

Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.

US Patent:

7774145, Aug 10, 2010

Filed:

Jan 18, 2006

Appl. No.:

11/334876

Inventors:

James H. Brauker - Cement City CA, US
Apurv Ullas Kamath - San Diego CA, US
Paul V. Goode - Cherry Hill NJ, US
Mark Brister - Encinitas CA, US

Assignee:

DexCom, Inc. - San Diego CA

International Classification:

G01N 33/50

US Classification:

702 19

Abstract:

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. In some embodiments, a device is provided for monitoring glucose concentration in a host, including a continuous glucose sensor and an integrated receiver including a single point glucose monitor. In some embodiments, a computer system is provided that determines a rate of change of continuous analyte sensor data.

US Patent:

7826891, Nov 2, 2010

Filed:

Sep 7, 2006

Appl. No.:

11/470926

Inventors:

Paul Goode - Murrieta CA, US

Assignee:

Cardiac Pacemakers, Inc. - St. Paul MN

International Classification:

A61B 5/053

US Classification:

600509, 607 17

Abstract:

The present invention relates to an implantable cardioverter-defibrillator or pacemaker whose standard circuitry is used to trend a physiological cardiac parameter using intra-cardiac impedance measurements. The trend information may be used to predict the onset of a sudden cardiac death (SCD) event. By being able to predict the onset of an SCD event, patients and their physicians may be forewarned of a life-threatening event allowing them to respond accordingly. The trend information may also be used to predict the efficacy of cardiac-related medications, monitor progress of congestive heart failure, detect the occurrence of myocardial infarction, or simply track changes in sympathetic tone.

US Patent:

7896809, Mar 1, 2011

Filed:

Nov 3, 2008

Appl. No.:

12/264160

Inventors:

Peter C. Simpson - Encinitas CA, US
James H. Brauker - Cement City MI, US
Paul V. Goode - Cherry HIll NJ, US
Apurv Ullas Kamath - San Diego CA, US
James R. Petisce - San Diego CA, US
Kum Ming Woo - San Diego CA, US
Melissa A. Nicholas - Monterey CA, US
Robert J. Boock - San Diego CA, US
Monica A. Rixman - San Diego CA, US
John Burd - San Diego CA, US
Rathburn K. Rhodes - Madison WI, US
Mark A. Tapsak - Orangeville PA, US

Assignee:

DexCom, Inc. - San Diego CA

International Classification:

A61B 5/05

US Classification:

600365, 600345, 600347

Abstract:

Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.